Activase (alteplase) is currently the only FDA-approved drug available for the treatment of acute ischemic stroke (AIS) in the 8MM*; however, novel drugs designed to …
Following a study published in The Lancet Oncology regarding a brand new type of cancer drug that has shown promise in multiple cancer types in …
Despite the ophthalmology market experiencing several research and development (R&D) setbacks during 2018, the launch of three new drugs highlights that the market still offers …
Scientists from ITMO University, Project 5-100 participant, have found a new way to effectively stop internal bleeding, one of the most frequent causes of deaths …
Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.
